Cellular identity and differentiation are determined by epigenetic programs. The characteristics of these programs in normal human mammary epithelium and their similarity to those in stem cells are unknown. To begin investigating these issues, we analyzed the DNA methylation and gene expression profiles of distinct subpopulations of mammary epithelial cells by using MSDK (methylationspecific digital karyotyping) and SAGE (serial analysis of gene expression). We identified discrete cell-type and differentiation state-specific DNA methylation and gene expression patterns that were maintained in a subset of breast carcinomas and correlated with clinically relevant tumor subtypes. CD44؉ cells were the most hypomethylated and highly expressed several transcription factors with known stem cell function including HOXA10 and TCF3. Many of these genes were also hypomethylated in BMP4-treated compared with undifferentiated human embryonic stem (ES) cells that we analyzed by MSDK for comparison. Further highlighting the similarity of epigenetic programs of embryonic and mammary epithelial cells, genes highly expressed in CD44؉ relative to more differentiated CD24؉ cells were significantly enriched for Suz12 targets in ES cells. The expression of FOXC1, one of the transcription factors hypomethylated and highly expressed in CD44؉ cells, induced a progenitor-like phenotype in differentiated mammary epithelial cells. These data suggest that epigenetically controlled transcription factors play a key role in regulating mammary epithelial cell phenotypes and imply similarities among epigenetic programs that define progenitor cell characteristics.
Cellular identity and differentiation are determined by epigenetic programs. The characteristics of these programs in normal human mammary epithelium and their similarity to those in stem cells are unknown. To begin investigating these issues, we analyzed the DNA methylation and gene expression profiles of distinct subpopulations of mammary epithelial cells by using MSDK (methylationspecific digital karyotyping) and SAGE (serial analysis of gene expression). We identified discrete cell-type and differentiation state-specific DNA methylation and gene expression patterns that were maintained in a subset of breast carcinomas and correlated with clinically relevant tumor subtypes. CD44؉ cells were the most hypomethylated and highly expressed several transcription factors with known stem cell function including HOXA10 and TCF3. Many of these genes were also hypomethylated in BMP4-treated compared with undifferentiated human embryonic stem (ES) cells that we analyzed by MSDK for comparison. Further highlighting the similarity of epigenetic programs of embryonic and mammary epithelial cells, genes highly expressed in CD44؉ relative to more differentiated CD24؉ cells were significantly enriched for Suz12 targets in ES cells. The expression of FOXC1, one of the transcription factors hypomethylated and highly expressed in CD44؉ cells, induced a progenitor-like phenotype in differentiated mammary epithelial cells. These data suggest that epigenetically controlled transcription factors play a key role in regulating mammary epithelial cell phenotypes and imply similarities among epigenetic programs that define progenitor cell characteristics.
cancer ͉ differentiation ͉ progenitor ͉ stem cell S tem cells are defined as cells with both self-renewal capacity and the ability to give rise to multiple distinct differentiated cell types. Recent studies have demonstrated the existence of cells with these properties in normal human breast epithelium (1) . However, the identity, molecular characteristics, and location of these cells are poorly defined. By using in vitro clonogenicity assays, several candidate human mammary epithelial progenitors have been identified, and numerous cell surface markers have been proposed for their enrichment, including MUC1, CD10, CD44, and ITGA6 (1) (2) (3) . These cells are thought to be restricted to the basal layer of terminal end ducts, and known stem cell pathways are activated in mammosphere cultures used to enrich for putative mammary stem cells (4) .
By using mouse mammary fat pad injection assays, lineage Ϫ / CD24 Ϫ/low /CD44 ϩ (''CD44ϩ'') breast tumor cells were found to be more tumorigenic than more differentiated CD44 Ϫ /CD24 ϩ (''CD24ϩ'') cells, identifying the CD44ϩ cells as human breast ''cancer stem cells'' (5) . We previously isolated these cells from primary breast tumors and similar cells from normal breast tissue and determined that their comprehensive gene expression profiles were consistent with the hypothesis that CD24ϩ and CD44ϩ cells represent differentiated luminal epithelial and progenitor-like cells, respectively (6) .
Epigenetic programs, including DNA methylation and chromatin patterns, play a key role in ES cell function and differentiation (7, 8) . Several genes important in pluripotency and self-renewal are hypomethylated and expressed in stem cells and silenced by methylation in differentiated cells (9) , suggesting that other genes that control stem cell characteristics, such as transcription factors, may be epigenetically regulated. The identity of mammary epithelial progenitor cell-specific epigenetic programs, their relatedness to those in ES cells and breast carcinomas, and which genes they regulate are undefined. To begin investigating these issues, we analyzed the comprehensive DNA methylation profiles of four distinct cell populations from normal human breast tissue, including CD44ϩ and CD24ϩ cells, and demonstrated that epigenetically controlled transcription factors seem to help define progenitor and differentiated cell phenotypes. Furthermore, we found that genes encoding transcription factors with known stem cell function are similarly methylated in CD44ϩ cells from normal mammary epithelium and some breast carcinomas and in BMP4-treated ES cells. These findings imply conservation of epigenetic programs that define progenitor characteristics. mary epithelium, we performed FACS analyses by using cell surface markers previously associated with luminal epithelial (MUC1 and CD24), myoepithelial (CD10), and progenitor (CD44) cell phenotypes [supporting information (SI) Fig. S1 A] . Then, we designed an immuno-magnetic bead purification procedure that minimized the overlap among cell fractions (Fig.  S1B) . By using this procedure, we isolated CD44ϩ, CD24ϩ, MUC1ϩ, and CD10ϩ cells from normal breast tissue of healthy women. Each cell fraction was isolated and characterized from multiple independent cases [see Tables S1 and S2 ]. The phenotypes of the enriched cell fractions were initially assessed by analyzing the expression of known differentiated and progenitor cell markers by semiquantitative RT-PCR (Fig. S1C and data not shown). CD24ϩ cells expressed luminal cell markers but were devoid of myoepithelial and progenitor cell markers, whereas CD44ϩ cells lacked lineage-specific genes and expressed multiple progenitor cell markers. MUC1ϩ cells were positive for luminal and some progenitor markers, implying that they may represent luminal lineage-committed progenitors or a mix of differentiated and progenitor cells. Similarly, CD10ϩ cells expressed myoepithelial and some progenitor markers.
To define the differences among the four cell types in further detail, we analyzed their gene expression profiles by using SAGE (10) . Hierarchical clustering of the SAGE libraries by using tags differentially expressed among the four cell types effectively separated the samples into two major basal/myoepithelial (CD44ϩ and CD10ϩ cells) and luminal (CD24ϩ and MUC1ϩ cells) branches that further subdivided into four branches by cell type (Fig. 1A) . Notably, known progenitor and differentiated cell markers were more abundant in the expected cell populations (Table S3) . A subset of genes in the ''basal/progenitor'' cluster was highly expressed in CD44ϩ cells, and it included several genes with known developmental and stem-cell function (e.g., MSC, BRD2, and ELF1), whereas a set of genes was common between CD10ϩ and CD44ϩ cells. These results confirmed our prior study of CD24ϩ and CD44ϩ cells (6) and determined that MUC1ϩ and CD10ϩ cells are distinct subsets of luminal epithelial and myoepithelial cells, respectively.
To define the functional differences among the four cell types, we classified the genes differentially expressed between CD44ϩ and either one of the other three cell types by using gene ontology (GO) terms. These analyses revealed that, compared with all three more differentiated cell types, CD44ϩ cells were enriched for genes encoding for proteins with extracellular function and roles in development and differentiation (Fig. 1B  and Table S4 ). Proteins specifically secreted by CD44ϩ cells included several chemokines (CCL2, CXCL2, and CXCL14), proteases (MMP2, MMP3, and MMP9), protease inhibitors (TIMP1-3), and cytokines involved in stem-cell signaling pathways such as TGFb (INHBA, BMP2, DCN, and LTBP4), WNT (SFRP and SFRP4), and Hedgehog (BGN). The enrichment of these genes in progenitor-like CD44ϩ cells compared with more differentiated CD24ϩ, MUC1ϩ, and CD10ϩ cells were consistent with the presumed in vivo function of these four cell populations.
To correlate the molecular profiles of the four cell types with their differentiation capacity, we performed colony growth assays in various culture conditions (Table S5 ). Colonies derived from CD10ϩ cells were homogenously positive for the basal/ myoepithelial markers cytokeratin 14 (CK14), smooth muscle actin (SMA), and vimentin (VIM), whereas MUC1ϩ and CD24ϩ cells formed uniform colonies positive for the luminal marker cytokeratin 18 (CK18) and negative for basal/ myoepithelial markers (CK14, VIM, and SMA) (Fig. 1C) . In contrast, CD44ϩ cells gave rise to different types of colonies depending on the media used. In media 1, most of the colonies were mesenchymal-like, CK14ϩ, VIMϩ, CK18Ϫ, and SMAϪ, whereas the majority of the colonies were epithelium-like and CK18ϩ in media 3 (Fig. 1D) . Media 1 and 3 had different additives (e.g., growth factors, hormones, and antioxidants), and media 3 was similar to the WIT medium (11) . In both media, a subset of the colonies was composed of a mix of CK18ϩ and CK14ϩ cells (Fig. 1D) , indicating that CD44ϩ cells can give rise to both luminal and myoepithelial cells. Thus, results of the colony growth assays correlated well with the in vivo expression patterns and presumed progenitor and differentiated-cell characteristics of the four cell types.
Cell Type-Specific DNA Methylation Patterns. Next, we analyzed the comprehensive DNA methylation profiles of each of the abovedescribed cell types by using MSDK, a comprehensive DNA methylation profiling technology previously developed in our lab (12) . By using a combination of methylation-sensitive (e.g., AscI) and nonsensitive (e.g., NlaIII) restriction enzymes, we derive short sequence tags from the genome. The number of these tags reflects the methylation status of each recognition site of the methylation-sensitive enzyme. Because we used AscI, our analysis is limited to its recognition sites. Nonetheless, we analyzed Ͼ5,000 unique tags corresponding to Ͼ4,000 genes from each sample, representing Ϸ 25% of all human coding genes associated with CpG islands (Table S6 and Fig. S2 A and B) . To identify AscI sites that were statistically significantly (P Ͻ 0.05) differentially methylated among the four different cell types, we performed pairwise and combined comparisons of MSDK libraries ( Fig. S3 and Table S7 ). These comparisons suggested that CD44ϩ cells are hypomethylated compared with each of the other three cell types.
To identify similarities between the DNA methylation profiles of ES and mammary epithelial cells, we performed MSDK analysis of undifferentiated (ES-UD) and BMP4-treated (ES-D) human embryonic stem cells (Fig. S1D) (13, 14) . Overall, undifferentiated ES cells were hypermethylated compared with BMP-4 treated ES cells, and interestingly, several loci hypomethylated in ES-UD compared with ES-D cells were also hypomethylated in CD44ϩ cells relative to CD24ϩ cells (Table S8) .
To further examine whether overall degree of DNA methylation correlates with cellular differentiation status, we calculated an arbitrary hypomethylation score for each sample defined by the abundance of MSDK tags corresponding to each AscI site present in each library. Based on this score, among mammary epithelial cells CD44ϩ, MUC1ϩ, and CD10ϩ cells were hypomethylated compared with CD24ϩ cells, whereas undifferentiated ES cells were more methylated compared with BMP-4-treated ES cells (Fig. 2A) . The observed differences in the overall degree of DNA methylation were not because of cell type-specific differences in DNMT (DNA methyl-transferase) expression, because this was fairly constant among samples (data not shown). These results suggest that DNA methylation profiles may be used as markers of cellular differentiation states. However, in the mammary epithelium more differentiated cells may be more methylated, whereas in ES cells differentiation may correlate with hypomethylation.
To determine which gene categories may be regulated by DNA methylation, we classified genes differentially methylated between CD44ϩ and each of the other three cell types by using gene ontology (GO) terms. We found that genes hypomethylated in CD44ϩ cells were highly enriched for transcription-related functions and involved in the regulation of cell proliferation and differentiation ( Fig. 2B and Table S4 ). In particular, several genes hypomethylated in CD44ϩ cells compared with CD24ϩ cells encode homeobox and polycomb proteins known to regulate stem cell function (Table 1) . HOXA10 is a target of the MLL-AF9 oncogene and is required for the self-renewal of hematopoietic stem cells (15) . Similarly, TCF7L1 (TCF3) is an upstream regulator of a transcription program involving OCT4, SOX2, and Nanog that is required for the pluripotency and self-renewal of ES cells (16). These data are consistent with the hypotheses that CD44ϩ cells include mammary epithelial progenitors and that their phenotype and differentiation, at least in part, are epigenetically regulated. Furthermore, our data also suggest that pluripotency and self-renewal may be regulated by an overlapping set of transcription factors in different stem cells.
To confirm the MSDK results for selected genes, we performed sequencing of bisulfite-treated genomic DNA and quantitative methylation-specific PCR (qMSP). . Not all genes were analyzed by both methods. The sequencing and qMSP results confirmed the cell type-specific methylation patterns demonstrated that these were consistent among samples derived from women of different ages (18-58 years old) and reproductive histories, although some variability in the degree of methylation was observed ( Fig. 2C and Fig. S4 ).
Conservation of Cell Type-Specific DNA Methylation Patterns in Breast
Carcinomas. Our recent analysis of gene expression profiles of CD24ϩ and CD44ϩ cells from normal and neoplastic breast tissue revealed a high degree of similarity between analogous cell types (6). To determine whether genes differentially methylated between normal CD44ϩ and CD24ϩ cells are also differentially methylated in analogous cell types from neoplastic tissue, we performed qMSP analyses of CD44ϩ and CD24ϩ cells isolated from five different breast tumors. The methylation of several genes was the same in tumor CD44ϩ and CD24ϩ cells as in their normal counterparts, although tumors were more variable than normal samples ( Fig. 2D and Fig. S5 ). Interestingly, the two tumors that were the most dissimilar to normal CD24ϩ and CD44ϩ cells (IDC31 and PE6) were both HER2ϩ, whereas all others were ERϩ, PRϩ, and HER2Ϫ. This suggests that the epigenetic profiles of progenitor-like cells in different tumor subtypes are distinct, potentially because of tumor-specific transforming events.
To further test the hypothesis that the epigenetic profiles defining progenitor-like cells are distinct in different breast cancer subtypes, we analyzed the methylation of PACAP, FOXC1, SLC9A3R1, and HOXA10 in a larger set (Ͼ100 cases) of invasive breast carcinomas from sporadic cases and from germ line BRCA1 and BRCA2 mutation carriers. These four genes were selected because they were the most consistently differentially methylated between CD44ϩ and CD24ϩ cells in the normal breast. Methylation of PACAP, FOXC1, and HOXA10 was statistically significantly associated with PR, ER, and HER2 status and correlated with luminal (ERϩ/PRϩ), HER2ϩ, and basal-like (ERϪ/PRϪ/HER2Ϫ) breast tumor subtypes (Table  S9) . Thus, the methylation pattern of luminal tumors resembled that of normal CD24ϩ cells, whereas HER2ϩ and basal-like tumors were more hypomethylated and similar to CD44ϩ cells. We previously demonstrated that a CD44ϩ breast cancer cell gene expression signature correlates with shorter distant metastasis-free survival (6) . To investigate whether this association is also true for cell type-specifically methylated genes, we analyzed the expression of five such genes in two independent cohorts of patients with clinical follow-up and microarray data (Fig. S6A ). In both datasets, patients with CD44ϩ cell-like tumors had statistically significantly shorter distant metastasis-free survival than patients with CD24ϩ cell-like tumors (Fig. S6A) .
To determine whether the epigenetic profiles of cancer cells are maintained during tumor progression, we analyzed the methylation profiles of matched primary tumors and distant metastases located in different organs in four independent patients. The methylation of HOXA10, FOXC1, and LHX1 (hypermethylated in CD24ϩ cells) was higher in distant metastases compared with primary tumors, whereas the methylation of PACAP and SLC9A3R1 showed more variability ( Fig. S6B and data not shown). These results suggest that distant metastases are enriched for hypermethylated CD24ϩ breast cancer cells, confirming our prior immunohistochemical analyses (6) . However, because almost all of the patients analyzed had ERϩ/PRϩ/ HER2Ϫ primary invasive breast carcinomas, our findings could be specific for this tumor subtype.
Associations Between DNA Methylation and Gene Expression Patterns. To determine the effect of methylation differences on gene expression patterns, we performed quantitative RT-PCR (qRT-PCR) of the same cells that were analyzed by qMSP (Fig. 3A) . Methylation of CpG islands in the promoter area or within the gene in general led to decreased expression (FNDC1, DDN, LHX1, HOXA10, FOXC1, and SOX13), whereas methylation at certain upstream (PACAP) or downstream (CDC42EP5) sites was associated with higher expression. Increased DNA methylation may lead to increased expression because of the inhibition of binding of silencers such as CTCF and BORIS (17) . Consistent with this hypothesis, the differentially methylated regions of PACAP and CDC42EP5 contain predicted CTCF/BORIS binding sites.
To obtain additional evidence to support our hypothesis that CD44ϩ cells include cells with progenitor properties and to further explore similarities of epigenetic programs of embryonic and putative adult stem cells, we analyzed whether genes differentially expressed between CD44ϩ and CD24ϩ cells are enriched for Suz12 targets. Suz12 is a member of PRC2 (Polycomb-Repressive Complex 2) associated with H3K27-containing nucleosomes, and it is essential for mouse embryonic development and ES cell differentiation (8, 18) . Targets of Suz12 have been identified based on genome-wide ChIP studies in ES cells, and many of them encode for proteins required for pluripotency and self-renewal (19, 20) . When we compared genes differentially expressed between CD44ϩ and CD24ϩ cells to Suz12 targets in ES cells, we found a statistically significant enrichment for Suz12 targets in genes highly expressed in CD44ϩ cells ( Fig.  3B and Table S10 ). Similar observations were made when analyzing genes differentially expressed between CD44ϩ cells and the other two (CD10ϩ and MUC1ϩ) cell types. Thus, CD44ϩ cells include cells with stem cell characteristics that seem to be defined by the same genes regardless of tissue type.
To further strengthen the association between the genes we identified as hypomethylated and expressed in CD44ϩ cells and mammary epithelial progenitors, we performed immunohistochemical analysis of four such genes (HOXA10, SOX13, HOXA11, and MSC) in normal human breast tissue. Occasional cells localized in the basal layer of the ducts and alveoli expressed these genes, consistent with the presumed location of mammary epithelial progenitors (Fig. 3C) . Double immunohistochemical analyses demonstrated that these cells were also positive for CD44v6, an epithelial-specific isoform of the marker used for their enrichment (Fig. 3D) . These results support our hypothesis that genes encoding transcription factors are candidates for epigenetically controlled regulators of the mammary epithelial progenitor cell phenotype because their methylation and expression patterns were consistently CD44ϩ cell -specific among samples and their in vivo expression correlated with the putative location of mammary epithelial progenitors.
Systemic Network Analysis of Cell Type-Specific Gene Expression and

DNA Methylation Patterns.
To further analyze signaling pathways and gene interaction networks that may play an important role in determining stem and differentiated mammary epithelial cell phenotypes, MSDK and SAGE data of the four distinct cell types from normal breast were subjected to functional analysis by using Metacore (21). First, we determined that genes differentially methylated or expressed in the four cell types were mapped to the same pathways and cellular processes (Figs. S7-S9 and Table  S11 and Table S12 ). Next, we analyzed both methylation and expression data for individual cell type-specific differences in signaling pathways and networks (Figs. S10 and S11). Genes highly expressed in CD24ϩ cells were enriched for insulinregulated pathways, mitochondrial metabolism, and apoptosis, whereas genes highly expressed in CD44ϩ cells were enriched for ECM (extracellular matrix) and cytoskeleton remodeling, integrin-mediated cell adhesion, immune response processes, and IL-4-mediated signaling (Table S13 ). The top-scoring ANR network for CD24ϩ cells included several DNA damage checkpoint genes (e.g., p53, Chk1, Chk2, and ATM), whereas MYC, AR, and TGF-␤/SMAD signaling predominated in CD44ϩ cells (Figs. S10 and S11). These results were consistent with the progenitor-like and luminal epithelial phenotypes of CD44ϩ and CD24ϩ cells, respectively.
FOXC1, a Candidate Regulator of Mammary Epithelial Progenitor Cell
Function. To further test the hypothesis that the transcription factors we identified as hypomethylated and highly expressed in CD44ϩ cells compared with the other three cell types may play a role in progenitor cell function, we determined the effect of the expression of FOXC1 in differentiated mammary epithelial cells. FOXC1 was a top candidate progenitor cell phenotype regulator because the FOXC1 interaction network was enriched for a number of other genes differentially methylated between CD24ϩ and CD44ϩ cells (e.g., IRX5, ROR-alpha, and BAI1) and included several key pathways regulating progenitor cell function, including FGF, TGF-␤, Notch, and WNT signaling (Fig. S12 A and B) . Genes with the most extensive network in a particular cell have been shown to be essential regulators of cellular phenotypes (22). FOXC1 was also the most hypomethylated and highly expressed in CD44ϩ cells among all cell types analyzed. Furthermore, FOXC1 has been shown to play an essential role in development, and its expression is regulated by Hedgehog and TGF-␤, both of which are important regulators of stem cell function (23) . Stable expression of FOXC1 in MCF12A cells resulted in the conversion of the differentiated epithelial phenotype to a CD44ϩ cell-like mesenchymal phenotype as determined by morphologic changes, increased cell migration and invasion, and altered gene expression patterns (Fig. 4 A-C) . Further studies are required to define the function of FOXC1 in the mammary gland, but this finding indicates that at least some of the cell type-specifically methylated genes we identified, particularly transcription factors, may play a role in the regulation of mammary epithelial progenitor and differentiated cell phenotypes. In summary, by using a combination of approaches, we identified candidate regulators of human mammary epithelial progenitors, markers that can be used to purify different mammary epithelial cell populations, and culture conditions for four cell types. Furthermore, we found cell type-specific DNA methylation programs that are maintained in breast carcinomas and correlate with tumor subtypes and clinical outcome. These data are valuable for the further characterization of the mammary epithelial cell hierarchy and understanding the regulatory pathways determining their phenotypes.
Materials and Methods
Detailed description of the procedures is in SI Text.
Tissue Samples and Cell Culture. Tissue specimens were collected without patient identifiers by using protocols approved by the Institutional Review Boards. Fresh samples were processed and distinct cell populations were isolated as described in ref. 6 . Details of tissue samples and culture conditions tested are described in Tables S1 and Table S5 , respectively.
Generation and Analyses of SAGE and MSDK Data. SAGE and MSDK libraries
were generated and analyzed as described previously by using the most recent human genome sequence information (6, 12) .
Pathway Map and Network Analyses By Using Metacore. Analysis was conducted in accordance with the Metacore analytical suite version 4.2 (GeneGo, Inc. St. Joseph, MI) manual and has been described previously (6, 21, 24) .
Bisulfite Sequencing, qMSP, and RT-PCR. Genomic DNA was bisulfite-treated and purified; qMSP and RT-PCR amplifications and sequencing were performed as previously described (12, 25) . A list of all primers used is available from the authors on request. Statistical significance of the differences in qMSP values among the various cell types and associations between qMSP and expression levels were calculated by using the Kruskal-Wallis test.
Immunohistochemistry. Immunohistochemical analysis for single markers was performed essentially as described in ref. 26 by using rabbit polyclonal HOXA10 (gift of Dr. Honami Naora, MD Anderson Cancer Center, Houston, TX), SOX13 (Sigma), HOX11 (Abnova), and MSC (Santa Cruz) antibodies.
DNA Constructs and FOXC1 Expression. Human FOXC1 cDNA was cloned into pWZL-blasto retroviral construct and used for retrovirus generation by using standard procedures. MCF-12A cells were infected with control or FOXC1-expressing retrovirus, and cells were selected in blasticidin-containing medium. Cells were plated in medium containing 2% Matrigel. Growth media used: Medium 1: MEBM plus supplements: B27, 20 ng/ml EGF, 20 ng/ml bFGF, and 4 g/ml heparin (bovine pituitary extract was excluded); Medium 2: DMEM/F12 plus 1 mM glutamine, 5 g/ml insulin, 500 ng/ml hydrocortisone, 10 ng/ml EGF, 20 ng/ml cholera toxin, and 0.1% BSA; Medium M3: equal mix of MEBM supplemented with 5.0 g/ml insulin, 70.0 g/ml bovine pituitary extract, 0.5 g/ml hydrocortisone, 5.0 ng/ml EGF, 5.0 g/ml transferrin, 10 nM isoproterenol, 2.0 mM glutamine, and DMEM/F12 supplemented with 10 g/ml insulin, 10 nM tri-iodothyronine, 1.0 nM 17b-estradiol, 0.1 g/ml hydrocortisone, 5 ng/ml EGF, 2 mM glutamine, 0.5% FCS and 4 ml of AlbuMAX (5% solution in water) with oxytocin added to 0.1 nM final concentration. For immunofluorescence, cells were fixed in 4% formaldehyde in PBS for 20 min at room temperature (RT) and permeabilized in 0.1% Triton X-100 for 5 min.
Nonspecific binding was blocked with 10% goat serum for 30 min., followed by incubation with primary antibody for 1 h and then with secondary antibody for 45 min at RT. To visualize nuclei, DAPI was included in secondary antibody incubation step at 0.2 g/ml final concentration.
Immunofluorescence. For immunofluorescence, cells were fixed in 4% formaldehyde in PBS for 20 min at room temperature (RT) and permeabilized in 0.1% Triton X-100 for 5 min. Nonspecific binding was blocked with 10% goat serum for 30 min, followed by incubation with primary antibody for 1 h and then with secondary antibody for 45 min at RT. To visualize nuclei, DAPI was included in secondary antibody incubation step at 0.2 g/ml final concentration.
Analysis of SAGE and MSDK Data. To identify differentially methylated tags MSDK libraries were merged and differentially methylated tags were determined based on Poisson analysis (http://genome.dfci.harvard.edu/sager/, P Ͻ 0.05). MSDK tags were mapped to genome (National Center for Biotechnology Information build 36) and genes nearest to tag associated AscI were collected. Ratios were drawn across the genome and where two or more ratios were involved a line is drawn between these ratios to denote they are linked to the same AscI site. Ratio points for genes of interest were circled and genes labeled. Differentially expressed genes were ordered evenly as a spectrum going from red (down-regulated genes) to black (no change genes) and to green (up-regulated genes). Yellow bars were used to mark 2-fold threshold. Suz12 target genes were marked in black bars and their densities (sum of target gene numbers in a window of 2% total gene number) were appended. Fisher exact tests were performed starting from two ends using a starting window with genes above the threshold, then moving toward midpoint using the same size windows, testing the enrichment of Suz12 targets inside the windows.
Pathway Map and Network Analyses Using METACORE. For enrichment analysis of gene lists in functional gene ontology categories lists of differentially methylated or expressed genes were analyzed for relative enrichment in certain functional ontology categories in Metacore, including GO and GeneGo cellular processes, and canonical pathways maps. P values were calculated using a basic formula for hypergeometric distribution where the P value essentially represents the probability of particular mapping arising by chance, given the number of genes in the set of all genes on maps/networks/processes, genes on a particular map/network/process and genes in the experiment.
For network visualization and analysis sets of genes differentially methylated or expressed in the four normal mammary epithelial cell types were uploaded into the Metacore analytical suite version 4.2 (GeneGo, Inc. St. Joseph, MI).
Immunohistochemistry. For double staining formalin-fixed, paraffin-embedded 5-M sections were mounted on glass slides, deparaffinized, and rehydrated through graded alcohols. For antigen retrieval, sections were immersed in 10 mM citrate buffer (pH 6.0) and heated in a pressure cooker (120°C for 5 min, followed by 90°C for 10 seconds). Slides were blocked with hydrogen peroxide, avidin, biotin, and serum, and incubated with anti-HoxA11 antibody at 1:200 overnight at 4°C. Slides were incubated with biotinylated secondary antibody followed by streptavidiperoxidase complex (Biogenex, San Ramon, CA) and 3,3Ј-diaminobenzidine as a substrate. Blocking steps were repeated and slides were incubated with anti-CD44v6 antibody (clone VFF-18, Millipore) at 1:400 for 1 h at room temperature. Detection with secondary antibody was repeated and slides were incubated with VIP substrate (Vector Labs, Burlingame, CA). Counterstaining was performed with Methyl green.
Statistical Analyses. To determine association of methylated status of the three genes (PACAP, SLC3A9R1, and FOXC1) and tumor ER/PR/HER2 and BRCA1/2 characteristics and to analyze association of methylated status of two additional genes (LHX1 and HOXA10) and tumor BRCA1/2 characteristics. Kruskal-Wallis tests were used to evaluate whether distributions of gene MSP methylation values were different among different tumor ER/PR/HER2 categories. Wilcoxon rank sum tests were used to evaluate if distributions of gene MSP methylation values were different between BRCA1 and BRCA2. Each of the three genes was tested separately.
Association with Clinical Outcome Analysis. Expression data on frozen primary tumor samples and follow-up clinical data about the patients involved were downloaded for Data Set 1 (from http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc ϭ GSE2034)
and Data Set 2 (from http://www.rii.com/publications/2002/ nejm.html and http://microarray-pubs.stanford.edu/woundNKI/ explore.html). The clinical data table for Data Set 1 listed sample 625 as having a relapse, but this was changed to relapsefree because all information on the National Center for Biotechnology Information database indicates that this patient is relapse-free. Only lymph node-negative tumors of patients who had not undergone chemotherapy or hormonal treatment were included in our analyses since Data Set 1 only contained patients of this type. Information about the microarray probes downloaded with the data was used to map them to official National Center for Biotechnology Information gene symbols. Data were log 2 -transformed, any flagged expression values were removed, and remaining values were median-centered by array. Microarray probes in the two datasets corresponding to genes identified as differentially expressed and methylated between CD44ϩ cells and other normal cell types in this study (CD24ϩ, MUC1ϩ, and CD10ϩ cells) were identified. Data for these probes were median-centered by gene. Then, only genes with probes with expression values Ͼ(mean ϩ standard deviation) or Ͻ(mean -standard deviation) in at least 10% of each dataset were kept for further analyses. All five remaining genes were hypomethylated in CD44ϩ cells, and the mRNA of one (PACAP) was low in these cells, while the mRNA of the other four (FOXC1, HOXA10, LHX1, and SOX13) was high. Logrank tests and Kaplan-Meier analysis were performed using GraphPad Prism 4 (GraphPad Software, 2005). Heat maps were created using MapleTree (developed by L. Simirenko). To determine the genes analyzed by our MSDK approach, we identified all genes nearby to be AscI sites. This revealed that AscI positions in relation to genes are not random as nearly half of the AscI sites fall inside a region that is Ϫ1,000 bp to ϩ 4,000 bp from a predicted transcriptional start site. Of the estimated 4,300 genes found near AscI sites, more than 3,600 genes (83%) have an AscI site located within the 20,000 bp promoter region or inside the gene. Thus, although not evaluating the entire genome, our method still provides a fairly comprehensive and unbiased DNA methylation analysis. For some genes the distance between the proximal promoter and the AscI site is large, but numerous data from several labs have demonstrated the existence of long-range regulatory elements that can function as enhancers (1) N1  48  reduction  normal  MUC1,CD10,CD24,CD44  qRT-PCR, qMSP  N2  22  reduction  normal  MUC1, BerEP4,CD10,CD24,CD44  SAGE  N3  24  reduction  normal  MUC1,CD10,CD24,CD44  qRT-PCR, qMSP  N5  58  reduction  normal  MUC1,CD10,CD24,CD44  qRT-PCR, qMSP, SAGE  N4  40-50  reduction  normal  MUC1,CD24, Total  3791  62  1166  74  172  46  216  62  Luminal  5622  39  1566  54  267  28  237  39  HER2ϩ  293  10  52  8  10  10  131  11  Basal  987  13  108  12  38  8  224 Table S3   Table S6   Table S7   Table S8   Table S10 
